Trials / Unknown
UnknownNCT04389424
Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer
Evaluation of the Relationship Between Drug Therapy, Food Consumption, Body Composition and Plasma Micronutients Levels With the Expression of Genes Related to Metabolism, Aging and Immunity in Women With Breast Cancer.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Instituto Jalisciense de Cancerologia · Other Government
- Sex
- Female
- Age
- 18 Years – 98 Years
- Healthy volunteers
- Not accepted
Summary
The protocol involves measurement of 25 hidroxy vitamin D, gene expression of cytochrome and vitamin D receptor , endoxifen, tamoxifen, exemestane, and other metobolites related to nutrition and endocrine metabolism.
Conditions
- Breast Cancer
- Endocrine Therapy
- Endocrine Therapy Adverse Reaction
- Vitamin D Deficiency
- Nutrition Disorders
- Obesity
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamoxifen | Use of tamoxifen for breast cancer recurrence prevention |
| DRUG | Exemestane | Use of exemestane for breast cancer recurrence prevention |
| DRUG | Anastrozole | Use of anastrozole for breast cancer recurrence prevention |
| DIAGNOSTIC_TEST | Basal | Initial diagnosis of breast cacner by biopsy or mastectomy |
| DIAGNOSTIC_TEST | Recurrence | Breast cancer recurrence under endocrine therapy |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2020-05-15
- Completion
- 2022-01-30
- First posted
- 2020-05-15
- Last updated
- 2020-05-15
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04389424. Inclusion in this directory is not an endorsement.